3D Cell-SELEX: Development of RNA aptamers as molecular probes for PC-3 tumor cell line

Experimental Cell Research
Aline G SouzaVivian A Goulart

Abstract

Human prostate cancer (PCa) is a highly heterogeneous and multifactorial disease. Current clinical biomarkers are not sufficiently accurate, thus being unable to predict the clinical outcome. Therefore, searching for new biomarkers aiming to improve diagnosis, prognosis and therapy is still required. In this study, we performed 3D Cell-SELEX against PC-3 prostate cancer cell line, a novel strategy to select specific nucleic acid ligands against spheroid cells in 3D cell culture. This original system combines Cell-SELEX, a process that exploits the cellular structure to generate specific ligands, and 3D cell culture, an approach that mimics the tissue microenvironment in vitro. In the first round of 3D Cell-SELEX, a negative selection against RWPE-1, non-tumor cell line, was performed to subtract non-tumor specific aptamers. The supernatant was used in eight additional rounds of selection, which were performed against PC-3 cell line. After nine selection cycles, eight PC-3 specific RNA aptamers were selected and sequenced. The aptamers presented sizes between 20 and 50 nucleotides-long, with low free energy (∆G<-13.6), which contributed for their spontaneous folding and high stability. Furthermore, our results showed the aptamer...Continue Reading

References

Aug 30, 1990·Nature·A D Ellington, J W Szostak
Feb 15, 1997·Nucleic Acids Research·B S SingerL Gold
May 30, 1998·Nucleic Acids Research·N Bardeesy, J Pelletier
Mar 30, 2005·BJU International·George YardyWalter Bodmer
Jul 11, 2006·Nature Biotechnology·James O McNamaraPaloma H Giangrande
Sep 21, 2006·Molecular Cancer Therapeutics·Kang Hyun ChoiSunjoo Jeong
Feb 23, 2008·Journal of Proteome Research·Dhimankrishna GhoshJohn A Wilkins
May 8, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jiehua ZhouJohn J Rossi
Mar 11, 2009·Journal of Proteome Research·Na LiAndrew D Ellington
Mar 28, 2009·International Journal of Molecular Sciences·Ke-Tai GuoHans P Wendel
May 26, 2009·Nucleic Acids Research·Yaroslav Chushak, Morley O Stone
Mar 17, 2010·Nature Nanotechnology·Glauco R SouzaRenata Pasqualini
Jun 12, 2010·Nature Protocols·Kwame SefahWeihong Tan
Jul 27, 2010·Bioanalysis·Yunfei ZhangWeihong Tan
Dec 21, 2010·PloS One·Kwame SefahWeihong Tan
Feb 9, 2011·Methods : a Companion to Methods in Enzymology·Pooja DuaDong-Ki Lee
Jun 7, 2011·Therapeutic Delivery·Kristina W Thiel, Paloma H Giangrande
Jun 21, 2011·PloS One·Na LiAndrew D Ellington
Aug 9, 2011·Biochemical and Biophysical Research Communications·Eun-Kyung LeeChan-Wha Kim
Jul 31, 2012·Experimental Cell Research·Louisa C E WindusVicky M Avery
Oct 18, 2012·Drug Discovery Today·Susan Breslin, Lorraine O'Driscoll
Dec 1, 2012·Cancer Letters·Sarah ShigdarWei Duan
Feb 13, 2013·Journal of Nucleic Acids·Yun Min ChangWeihong Tan
Mar 22, 2013·BioResearch Open Access·Shoji Ohuchi
Apr 9, 2013·Biochimica Et Biophysica Acta·Giorgia ZadraMassimo Loda
Sep 14, 2013·Nature Protocols·William L HaislerGlauco R Souza
Nov 5, 2013·Biotechnology Advances·Zhaohui Li, Zhanfeng Cui
Mar 19, 2014·Advanced Drug Delivery Reviews·Claudio R ThomaWilhelm Krek
Oct 2, 2014·Scientific Reports·Hamsa JaganathanBiana Godin
Dec 30, 2014·Journal of Biotechnology·Jong Bong LeeSunghoon Kim
Apr 17, 2015·Science Translational Medicine·Kandice Tanner, Michael M Gottesman
Jul 16, 2015·Scientific Reports·Karina MarangoniLuiz R Goulart

❮ Previous
Next ❯

Citations

Aug 27, 2016·Cellular and Molecular Life Sciences : CMLS·Jing QuJianliang Zhang
Dec 16, 2016·International Journal of Molecular Sciences·Man ChenGe Zhang
Jan 26, 2017·Journal of the American Chemical Society·Liqin ZhangWeihong Tan
Aug 26, 2017·International Journal of Molecular Sciences·Xiaoqiu WuGe Zhang
Oct 19, 2017·International Journal of Molecular Sciences·Zhenjian ZhuoBaoting Zhang
Dec 1, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Kamal RahimizadehRakesh N Veedu
Jun 22, 2018·Oncotarget·Ricardo L PereiraHenning Ulrich
Aug 15, 2017·Biomedicines·Silvia Catuogno, Carla Lucia Esposito
Jul 15, 2020·Pharmaceutics·Prabir Kumar KulabhusanMeral Yüce
May 20, 2017·International Journal of Molecular Sciences·Pujan K DesaiGlauco R Souza
Jun 22, 2017·Cancers·Marie-Cécile MercierLaurence Choulier
Jun 6, 2018·Frontiers in Molecular Biosciences·Priya KalraTarun K Sharma
Nov 16, 2018·Pharmaceuticals·Simona CamoraniLaura Cerchia
Sep 14, 2018·Pharmaceuticals·Dario Ruiz CiancioMaría Belén Mestre
Oct 17, 2017·Analytical and Bioanalytical Chemistry·Bruno P CrulhasValber A Pedrosa
Jul 2, 2019·International Journal of Pharmaceutics·Marimuthu CitartanThean-Hock Tang
Mar 6, 2021·Chemical Reviews·Lingling WuWeihong Tan
May 1, 2021·Pharmaceuticals·Frank H T NelissenHans A Heus
Jun 3, 2021·International Journal of Molecular Sciences·Dhruvajyoti RoyJudith C Sporn
Aug 8, 2021·Applied Biochemistry and Biotechnology·Mariane Izabella Abreu de MeloDawidson Assis Gomes
Mar 3, 2020·ACS Omega·Esther Campos-FernándezVivian Alonso-Goulart
Aug 25, 2021·Biotechnology and Applied Biochemistry·Michael Kohlberger, Gabriele Gadermaier

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.